Published in J Biol Chem on March 16, 2010
mTOR signaling in growth control and disease. Cell (2012) 29.21
Regulation of mTORC1 and its impact on gene expression at a glance. J Cell Sci (2013) 2.22
Rapalogs and mTOR inhibitors as anti-aging therapeutics. J Clin Invest (2013) 2.14
Where is mTOR and what is it doing there? J Cell Biol (2013) 1.91
mTOR associates with TFIIIC, is found at tRNA and 5S rRNA genes, and targets their repressor Maf1. Proc Natl Acad Sci U S A (2010) 1.57
5S ribosomal RNA is an essential component of a nascent ribosomal precursor complex that regulates the Hdm2-p53 checkpoint. Cell Rep (2013) 1.37
mTORC1 directly phosphorylates and regulates human MAF1. Mol Cell Biol (2010) 1.24
mTOR phosphorylates IMP2 to promote IGF2 mRNA translation by internal ribosomal entry. Genes Dev (2011) 1.21
Review series: TOR kinase complexes and cell migration. J Cell Biol (2011) 1.19
Regulation of mRNA translation by signaling pathways. Cold Spring Harb Perspect Biol (2012) 1.13
Nutrient/TOR-dependent regulation of RNA polymerase III controls tissue and organismal growth in Drosophila. EMBO J (2012) 1.08
Regulation of pol III transcription by nutrient and stress signaling pathways. Biochim Biophys Acta (2012) 1.04
mTOR: a link from the extracellular milieu to transcriptional regulation of oligodendrocyte development. ASN Neuro (2013) 0.99
Phosphoproteomic profiling of in vivo signaling in liver by the mammalian target of rapamycin complex 1 (mTORC1). PLoS One (2011) 0.98
Activation of mTOR (mechanistic target of rapamycin) in rheumatic diseases. Nat Rev Rheumatol (2015) 0.96
Nuclear PI3K signaling in cell growth and tumorigenesis. Front Cell Dev Biol (2015) 0.96
mTOR Signaling in Protein Translation Regulation: Implications in Cancer Genesis and Therapeutic Interventions. Mol Biol Int (2014) 0.92
Regulation of human RNA polymerase III transcription by DNMT1 and DNMT3a DNA methyltransferases. J Biol Chem (2012) 0.90
Spatiotemporal characterization of mTOR kinase activity following kainic acid induced status epilepticus and analysis of rat brain response to chronic rapamycin treatment. PLoS One (2013) 0.88
Covalent small ubiquitin-like modifier (SUMO) modification of Maf1 protein controls RNA polymerase III-dependent transcription repression. J Biol Chem (2013) 0.87
Physiological roles for mafr-1 in reproduction and lipid homeostasis. Cell Rep (2014) 0.87
mTORC1 and mTORC2 in cancer and the tumor microenvironment. Oncogene (2016) 0.85
tRNA and cytochrome c in cell death and beyond. Cell Cycle (2010) 0.85
MAF1 suppresses AKT-mTOR signaling and liver cancer through activation of PTEN transcription. Hepatology (2016) 0.84
Human MAF1 targets and represses active RNA polymerase III genes by preventing recruitment rather than inducing long-term transcriptional arrest. Genome Res (2016) 0.83
A liaison between mTOR signaling, ribosome biogenesis and cancer. Biochim Biophys Acta (2015) 0.83
Imaging RNA polymerase III transcription using a photostable RNA-fluorophore complex. Nat Chem Biol (2017) 0.82
Proteomics: a strategy to understand the novel targets in protein misfolding and cancer therapy. Expert Rev Proteomics (2010) 0.81
Recovery of RNA polymerase III transcription from the glycerol-repressed state: revisiting the role of protein kinase CK2 in Maf1 phosphoregulation. J Biol Chem (2012) 0.80
Signaling crosstalk between the mTOR complexes. Translation (Austin) (2014) 0.80
Regulation of cell death by transfer RNA. Antioxid Redox Signal (2013) 0.80
Mammalian target of rapamycin complex 1 (mTORC1)-mediated phosphorylation stabilizes ISCU protein: implications for iron metabolism. J Biol Chem (2013) 0.79
Cyr61, a matricellular protein, is needed for dendritic arborization of hippocampal neurons. J Biol Chem (2013) 0.79
Alu retrotransposons promote differentiation of human carcinoma cells through the aryl hydrocarbon receptor. Nucleic Acids Res (2016) 0.78
Deptor transcriptionally regulates endoplasmic reticulum homeostasis in multiple myeloma cells. Oncotarget (2016) 0.78
Citrus MAF1, a repressor of RNA polymerase III, binds the Xanthomonas citri canker elicitor PthA4 and suppresses citrus canker development. Plant Physiol (2013) 0.78
mTOR complex-2 stimulates acetyl-CoA and de novo lipogenesis through ATP citrate lyase in HER2/PIK3CA-hyperactive breast cancer. Oncotarget (2016) 0.78
Maf1, A New PTEN Target Linking RNA and Lipid Metabolism. Trends Endocrinol Metab (2016) 0.77
A quantitative transcriptomic analysis of the physiological significance of mTOR signaling in goat fetal fibroblasts. BMC Genomics (2016) 0.75
Plasmodium falciparum Maf1 Confers Survival upon Amino Acid Starvation. MBio (2017) 0.75
The C-box region of MAF1 regulates transcriptional activity and protein stability. J Mol Biol (2016) 0.75
Mammalian target of rapamycin (mTOR) as a potential therapeutic target in various diseases. Inflammopharmacology (2017) 0.75
TORC1-Dependent Phosphorylation Targets in Fission Yeast. Biomolecules (2017) 0.75
Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods (2001) 414.27
Defining the role of mTOR in cancer. Cancer Cell (2007) 21.63
ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage. Science (2007) 20.11
Molecular mechanisms of mTOR-mediated translational control. Nat Rev Mol Cell Biol (2009) 13.89
Targeting PI3K signalling in cancer: opportunities, challenges and limitations. Nat Rev Cancer (2009) 12.92
An ATP-competitive mammalian target of rapamycin inhibitor reveals rapamycin-resistant functions of mTORC1. J Biol Chem (2009) 12.73
A quantitative atlas of mitotic phosphorylation. Proc Natl Acad Sci U S A (2008) 10.07
PI3K pathway alterations in cancer: variations on a theme. Oncogene (2008) 9.94
Active-site inhibitors of mTOR target rapamycin-resistant outputs of mTORC1 and mTORC2. PLoS Biol (2009) 9.63
PhosphoSite: A bioinformatics resource dedicated to physiological protein phosphorylation. Proteomics (2004) 5.55
The PTEN-PI3K pathway: of feedbacks and cross-talks. Oncogene (2008) 4.39
Activation of mouse genes in transformed cells. Cell (1983) 3.85
Characterization of the rapamycin-sensitive phosphoproteome reveals that Sch9 is a central coordinator of protein synthesis. Genes Dev (2009) 3.31
Retracted Elevated tRNA(iMet) synthesis can drive cell proliferation and oncogenic transformation. Cell (2008) 3.23
Profiling of UV-induced ATM/ATR signaling pathways. Proc Natl Acad Sci U S A (2007) 3.12
Biochemical, cellular, and in vivo activity of novel ATP-competitive and selective inhibitors of the mammalian target of rapamycin. Cancer Res (2009) 3.03
mTOR-dependent activation of the transcription factor TIF-IA links rRNA synthesis to nutrient availability. Genes Dev (2004) 2.96
Rapamycin induces the G0 program of transcriptional repression in yeast by interfering with the TOR signaling pathway. Mol Cell Biol (1998) 2.91
mTOR-dependent regulation of ribosomal gene transcription requires S6K1 and is mediated by phosphorylation of the carboxy-terminal activation domain of the nucleolar transcription factor UBF. Mol Cell Biol (2003) 2.68
Nutrient regulates Tor1 nuclear localization and association with rDNA promoter. Nature (2006) 2.20
New insights into mTOR signaling: mTORC2 and beyond. Sci Signal (2009) 2.08
Mammalian target of rapamycin complex 1: signalling inputs, substrates and feedback mechanisms. Cell Signal (2009) 2.07
Response and determinants of cancer cell susceptibility to PI3K inhibitors: combined targeting of PI3K and Mek1 as an effective anticancer strategy. Cancer Biol Ther (2007) 2.02
RNA polymerases I and III, non-coding RNAs and cancer. Trends Genet (2008) 1.91
General repression of RNA polymerase III transcription is triggered by protein phosphatase type 2A-mediated dephosphorylation of Maf1. Mol Cell (2006) 1.90
Beyond rapalog therapy: preclinical pharmacology and antitumor activity of WYE-125132, an ATP-competitive and specific inhibitor of mTORC1 and mTORC2. Cancer Res (2010) 1.86
Regulation of RNA polymerase III transcription in response to F9 embryonal carcinoma stem cell differentiation. Cell (1989) 1.81
Cytoplasmic-nuclear shuttling of FKBP12-rapamycin-associated protein is involved in rapamycin-sensitive signaling and translation initiation. Proc Natl Acad Sci U S A (2000) 1.77
Dephosphorylation and genome-wide association of Maf1 with Pol III-transcribed genes during repression. Mol Cell (2006) 1.74
Mammalian Maf1 is a negative regulator of transcription by all three nuclear RNA polymerases. Mol Cell (2007) 1.70
RNA polymerase III transcription factor TFIIIC2 is overexpressed in ovarian tumors. Proc Natl Acad Sci U S A (2000) 1.64
Non-coding RNA production by RNA polymerase III is implicated in cancer. Nat Rev Cancer (2008) 1.62
Predominant nuclear localization of mammalian target of rapamycin in normal and malignant cells in culture. J Biol Chem (2002) 1.61
Different human TFIIIB activities direct RNA polymerase III transcription from TATA-containing and TATA-less promoters. Genes Dev (2000) 1.61
Maf1, a new player in the regulation of human RNA polymerase III transcription. PLoS One (2006) 1.54
PTEN represses RNA polymerase III-dependent transcription by targeting the TFIIIB complex. Mol Cell Biol (2008) 1.53
Regulation of RNA polymerase III transcription involves SCH9-dependent and SCH9-independent branches of the target of rapamycin (TOR) pathway. J Biol Chem (2009) 1.51
Phosphatidylinositol 3-kinase and mTOR signaling pathways regulate RNA polymerase I transcription in response to IGF-1 and nutrients. J Biol Chem (2003) 1.45
RNAPol-ChIP analysis of transcription from FSHD-linked tandem repeats and satellite DNA. Biochim Biophys Acta (2006) 1.35
Mechanisms of regulation of RNA polymerase III-dependent transcription by TORC1. EMBO J (2009) 1.34
Regulation of the RNA polymerase I and III transcription systems in response to growth conditions. J Biol Chem (1996) 1.32
Regulation of RNA polymerase III transcription in response to Simian virus 40 transformation. EMBO J (1990) 1.31
Regulation of RNA polymerase III transcription by Maf1 in mammalian cells. J Mol Biol (2008) 1.29
A nuclear transport signal in mammalian target of rapamycin is critical for its cytoplasmic signaling to S6 kinase 1. J Biol Chem (2006) 1.16
Human Maf1 negatively regulates RNA polymerase III transcription via the TFIIB family members Brf1 and Brf2. Int J Biol Sci (2007) 1.16
Global profiling of phosphopeptides by titania affinity enrichment. J Proteome Res (2007) 1.11
Facilitated recycling protects human RNA polymerase III from repression by Maf1 in vitro. J Biol Chem (2008) 1.01
The regulation of RNA synthesis in yeast II: Amino acids shift-up experiments. Mol Gen Genet (1977) 0.99
Structure-function analysis of the human TFIIB-related factor II protein reveals an essential role for the C-terminal domain in RNA polymerase III transcription. Mol Cell Biol (2005) 0.91
Synthesis and structure-activity relationships of ring-opened 17-hydroxywortmannins: potent phosphoinositide 3-kinase inhibitors with improved properties and anticancer efficacy. J Med Chem (2008) 0.87
Safety and immunogenicity of 2009 pandemic influenza A H1N1 vaccines in China: a multicentre, double-blind, randomised, placebo-controlled trial. Lancet (2009) 3.97
An embryonic stem cell chromatin remodeling complex, esBAF, is essential for embryonic stem cell self-renewal and pluripotency. Proc Natl Acad Sci U S A (2009) 3.82
Quantification of C-reactive protein in the serum of patients with rheumatoid arthritis using multiple reaction monitoring mass spectrometry and 13C-labeled peptide standards. Proteomics (2004) 3.57
Ammonia derived from glutaminolysis is a diffusible regulator of autophagy. Sci Signal (2010) 3.38
Biochemical, cellular, and in vivo activity of novel ATP-competitive and selective inhibitors of the mammalian target of rapamycin. Cancer Res (2009) 3.03
The light peak of the electroretinogram is dependent on voltage-gated calcium channels and antagonized by bestrophin (best-1). J Gen Physiol (2006) 2.18
Response and determinants of cancer cell susceptibility to PI3K inhibitors: combined targeting of PI3K and Mek1 as an effective anticancer strategy. Cancer Biol Ther (2007) 2.02
Mammalian target of rapamycin: discovery of rapamycin reveals a signaling pathway important for normal and cancer cell growth. Semin Oncol (2009) 1.98
Cilostazol as an alternative to aspirin after ischaemic stroke: a randomised, double-blind, pilot study. Lancet Neurol (2008) 1.98
The BAF complex interacts with Pax6 in adult neural progenitors to establish a neurogenic cross-regulatory transcriptional network. Cell Stem Cell (2013) 1.96
Targeting mTOR globally in cancer: thinking beyond rapamycin. Cell Cycle (2009) 1.89
Beyond rapalog therapy: preclinical pharmacology and antitumor activity of WYE-125132, an ATP-competitive and specific inhibitor of mTORC1 and mTORC2. Cancer Res (2010) 1.86
Use of mass spectrometry to identify protein biomarkers of disease severity in the synovial fluid and serum of patients with rheumatoid arthritis. Arthritis Rheum (2004) 1.82
1.3-μm InAs/GaAs quantum-dot lasers monolithically grown on Si substrates using InAlAs/GaAs dislocation filter layers. Opt Express (2014) 1.82
A new pharmacologic action of CCI-779 involves FKBP12-independent inhibition of mTOR kinase activity and profound repression of global protein synthesis. Cancer Res (2008) 1.81
In vivo tumor targeting of tumor necrosis factor-alpha-loaded stealth nanoparticles: effect of MePEG molecular weight and particle size. Eur J Pharm Sci (2005) 1.72
PWT-458, a novel pegylated-17-hydroxywortmannin, inhibits phosphatidylinositol 3-kinase signaling and suppresses growth of solid tumors. Cancer Biol Ther (2005) 1.70
Olig2 targets chromatin remodelers to enhancers to initiate oligodendrocyte differentiation. Cell (2013) 1.66
Origins of 1/f noise in nanostructure inclusion polymorphous silicon films. Nanoscale Res Lett (2011) 1.54
Oxidative injury and hepatocyte apoptosis in total parenteral nutrition-associated liver dysfunction. J Pediatr Surg (2006) 1.53
Surveillance of macrolide-resistant Mycoplasma pneumoniae in Beijing, China, from 2008 to 2012. Antimicrob Agents Chemother (2012) 1.51
What if a patient with atrial fibrillation and anticoagulant treatment is suffering from acute ischemia stroke? Cerebrovasc Dis (2013) 1.45
Identification of unknown residue 55 in bovine folate binding protein: fingerprint matching and sequencing of a doubly tagged peptide fragment by ion trap mass spectrometry. Rapid Commun Mass Spectrom (2003) 1.41
Anti-tumor necrosis factor-α monoclonal antibody alleviates parenteral nutrition-associated liver disease in mice. JPEN J Parenter Enteral Nutr (2012) 1.39
Enhanced magnetic resonance imaging of Guillain-Barré syndrome. J Paediatr Child Health (2011) 1.38
InGaAs Quantum Well Grown on High-Index Surfaces for Superluminescent Diode Applications. Nanoscale Res Lett (2010) 1.37
Origin of nanohole formation by etching based on droplet epitaxy. Nanoscale (2014) 1.34
Chemical regulation of epigenetic modifications: opportunities for new cancer therapy. Med Res Rev (2008) 1.32
Field emission from in situ-grown vertically aligned SnO2 nanowire arrays. Nanoscale Res Lett (2012) 1.31
MYST protein acetyltransferase activity requires active site lysine autoacetylation. EMBO J (2011) 1.29
Roles of T helper 17 cells and interleukin-17 in neuroautoimmune diseases with emphasis on multiple sclerosis and Guillain-Barré syndrome as well as their animal models. J Neurosci Res (2013) 1.21
Chinese guidelines for the secondary prevention of ischemic stroke and transient ischemic attack 2010. CNS Neurosci Ther (2012) 1.20
Mutations in Lama1 disrupt retinal vascular development and inner limiting membrane formation. J Biol Chem (2010) 1.19
Membrane frizzled-related protein is necessary for the normal development and maintenance of photoreceptor outer segments. Vis Neurosci (2008) 1.18
Hybrid inhibitors of phosphatidylinositol 3-kinase (PI3K) and the mammalian target of rapamycin (mTOR): design, synthesis, and superior antitumor activity of novel wortmannin-rapamycin conjugates. J Med Chem (2010) 1.17
Multiple-locus variable-number tandem-repeat analysis of 201 Mycoplasma pneumoniae isolates from Beijing, China, from 2008 to 2011. J Clin Microbiol (2012) 1.16
A myocardin-related transcription factor regulates activity of serum response factor in Drosophila. Proc Natl Acad Sci U S A (2004) 1.16
Pyranonaphthoquinone lactones: a new class of AKT selective kinase inhibitors alkylate a regulatory loop cysteine. J Med Chem (2009) 1.15
Suppression of acute rejective response following orthotopic liver transplantation in experimental rats infected with Echinococcus multilocularis. Chin Med J (Engl) (2011) 1.15
The immune-modulatory role of apolipoprotein E with emphasis on multiple sclerosis and experimental autoimmune encephalomyelitis. Clin Dev Immunol (2010) 1.15
Suppression of Ca2+ signaling in a mouse model of Best disease. Hum Mol Genet (2010) 1.14
Atypical Sturge-Weber syndrome requires confirmation. Eur J Paediatr Neurol (2013) 1.11
Global profiling of phosphopeptides by titania affinity enrichment. J Proteome Res (2007) 1.11
Cross-talk between apolipoprotein E and cytokines. Mediators Inflamm (2011) 1.11
Different impacts of blood pressure variability on the progression of cerebral microbleeds and white matter lesions. Stroke (2012) 1.10
Chronic lymphocytic inflammation with Pontine perivascular enhancement responsive to steroids and fatal B-cell lymphoma. JAMA Neurol (2013) 1.09
Preparation, characterization and in vitro cytotoxicity of indomethacin-loaded PLLA/PLGA microparticles using supercritical CO2 technique. Eur J Pharm Biopharm (2008) 1.09
Apolipoprotein E4 and psoriasis. Arch Dermatol Res (2009) 1.08
Randomized controlled trial of dual antiplatelet therapy in patients undergoing surgery for critical limb ischemia. Ann Surg (2014) 1.07
Wingspan stenting of symptomatic middle cerebral artery stenosis and perioperative evaluation using high-resolution 3 Tesla MRI. J Clin Neurosci (2012) 1.07
Meta-analysis of B vitamin supplementation on plasma homocysteine, cardiovascular and all-cause mortality. Clin Nutr (2013) 1.06
Acute motor-sensory axonal neuropathy and Helicobacter pylori infections. J Neurosurg Spine (2013) 1.06
Myasthenia gravis and Guillain-Barré cooccurrence syndrome. Am J Emerg Med (2013) 1.06
Hydrogen bonding-induced aromatic oligoamide foldamers as spherand analogues to accelerate the hydrolysis of nitro-substituted anisole in aqueous media. J Org Chem (2007) 1.06
The effect of various intensities of physical activity and chronic inflammation in men and women by diabetes status in a national sample. Diabetes Res Clin Pract (2012) 1.05
Primary intestinal lymphangiectasia: four case reports and a review of the literature. Dig Dis Sci (2010) 1.05
Reconstruction of a huge oral maxillofacial defect caused by necrotic fasciitis secondary to leukaemia. J Plast Reconstr Aesthet Surg (2008) 1.04
Emergent stent placement following intra-arterial thrombolysis for the treatment of acute basilar artery occlusion. J Clin Neurosci (2011) 1.02
SP1 transcription factors in male germ cell development and differentiation. Mol Cell Endocrinol (2007) 1.01
Efficacy and pharmacodynamic effects of bosutinib (SKI-606), a Src/Abl inhibitor, in freshly generated human pancreas cancer xenografts. Mol Cancer Ther (2009) 1.01
Increased hippocampal neurogenesis in the progressive stage of Alzheimer's disease phenotype in an APP/PS1 double transgenic mouse model. Hippocampus (2009) 1.01
Heterotrimeric G proteins regulate a noncanonical function of septate junction proteins to maintain cardiac integrity in Drosophila. Dev Cell (2008) 1.00
NF-κB forms a complex with the chromatin remodeler BRG1 to regulate Schwann cell differentiation. J Neurosci (2013) 0.98
TLR9/TLR7-triggered downregulation of BDCA2 expression on human plasmacytoid dendritic cells from healthy individuals and lupus patients. Clin Immunol (2008) 0.98
Pegylated wortmannin and 17-hydroxywortmannin conjugates as phosphoinositide 3-kinase inhibitors active in human tumor xenograft models. J Med Chem (2006) 0.98
A first meningococcal meningitis case caused by serogroup X Neisseria meningitidis strains in China. Chin Med J (Engl) (2008) 0.98
Activity of the tetrapyrrole regulator CrtJ is controlled by oxidation of a redox active cysteine located in the DNA binding domain. Mol Microbiol (2012) 0.98
Discovery of lactoquinomycin and related pyranonaphthoquinones as potent and allosteric inhibitors of AKT/PKB: mechanistic involvement of AKT catalytic activation loop cysteines. Mol Cancer Ther (2007) 0.98
Compensatory remodeling in symptomatic middle cerebral artery atherosclerotic stenosis: a high-resolution MRI and microemboli monitoring study. Neurol Res (2012) 0.98
Function of the active site lysine autoacetylation in Tip60 catalysis. PLoS One (2012) 0.97
Detection of autoantibodies against gangliosides in Guillain-Barré syndrome. Iran J Immunol (2010) 0.96
6-alkylsalicylates are selective Tip60 inhibitors and target the acetyl-CoA binding site. Eur J Med Chem (2011) 0.95
Inactivation of glycogen synthase kinase-3beta and up-regulation of LINGO-1 are involved in LINGO-1 antagonist regulated survival of cerebellar granular neurons. Cell Mol Neurobiol (2008) 0.94
Integrating titania enrichment, iTRAQ labeling, and Orbitrap CID-HCD for global identification and quantitative analysis of phosphopeptides. Proteomics (2010) 0.93
Endemic and imported measles virus-associated outbreaks among adults, Beijing, China, 2013. Emerg Infect Dis (2015) 0.93
Ethnic differences in body composition and obesity related risk factors: study in Chinese and white males living in China. PLoS One (2011) 0.92
Rolloamides A and B, cytotoxic cyclic heptapeptides isolated from the Caribbean marine sponge Eurypon laughlini. J Nat Prod (2009) 0.92
Large-scale seroprevalence analysis of human metapneumovirus and human respiratory syncytial virus infections in Beijing, China. Virol J (2011) 0.92
Nonylphenol induces apoptosis in rat testicular Sertoli cells via endoplasmic reticulum stress. Toxicol Lett (2009) 0.91
Inhibitory study of protein arginine methyltransferase 1 using a fluorescent approach. Biochem Biophys Res Commun (2008) 0.91
Case fatality rate of severe acute respiratory syndromes in Beijing. Biomed Environ Sci (2005) 0.91
The utility of pathway selective estrogen receptor ligands that inhibit nuclear factor-kappa B transcriptional activity in models of rheumatoid arthritis. Arthritis Res Ther (2005) 0.91
The toxic effects of microcystin-LR on rat spermatogonia in vitro. Toxicol Lett (2012) 0.91
Identification and characterization of a constitutively T-loop phosphorylated and active recombinant S6K1: expression, purification, and enzymatic studies in a high capacity non-radioactive TR-FRET Lance assay. Protein Expr Purif (2005) 0.91
Accuracy of IgM antibody testing, FQ-PCR and culture in laboratory diagnosis of acute infection by Mycoplasma pneumoniae in adults and adolescents with community-acquired pneumonia. BMC Infect Dis (2013) 0.90
The role of apolipoprotein E in Guillain-Barré syndrome and experimental autoimmune neuritis. J Biomed Biotechnol (2010) 0.90
Intracranial hypotension and PRES. J Headache Pain (2010) 0.90
Human neural stem/progenitor cells derived from embryonic stem cells and fetal nervous system present differences in immunogenicity and immunomodulatory potentials in vitro. Stem Cell Res (2013) 0.90
DARPP-32 to quantify intracerebral hemorrhage-induced neuronal death in basal ganglia. Transl Stroke Res (2012) 0.90
Incorporation of water-solubilizing groups in pyrazolopyrimidine mTOR inhibitors: discovery of highly potent and selective analogs with improved human microsomal stability. Bioorg Med Chem Lett (2009) 0.90
Autoacetylation of the MYST lysine acetyltransferase MOF protein. J Biol Chem (2012) 0.89
Identification of 2-oxatriazines as highly potent pan-PI3K/mTOR dual inhibitors. Bioorg Med Chem Lett (2011) 0.89
Homozygous deletion of the CRABPI gene in AB1 embryonic stem cells results in increased CRABPII gene expression and decreased intracellular retinoic acid concentration. Arch Biochem Biophys (2003) 0.89